{"id":"NHA000174","research":"hum0354","url":"https://humandbs.dbcls.jp/dataset/NHA000174","datePublished":"2022-06-30","dateModified":"2022-06-30","values":[{"key":"access-criteria","label":{"ja":"アクセス制限","en":"Access criteria"},"type":"vocabulary","terms":[{"code":"unrestricted-access","label":{"ja":"非制限公開","en":"Unrestricted-access"}}]},{"key":"type-of-data","label":{"ja":"データの種類","en":"Type of data"},"type":"text","text":{"ja":"qRT-PCR","en":"qRT-PCR"}}],"experiments":[{"label":"qRT-PCR (AR-V7)","values":[{"key":"materials-and-participants","label":{"ja":"材料と対象者","en":"Materials and participants"},"type":"text","text":{"ja":"進行転移性CRPC（ICD-10：C61）：127症例\n1. cabazitaxel使用の48症例（CTC 150検体）\n2. enzalutamide使用の90症例（CTC 46検体）","en":"CRPC (ICD10: C61): 127 cases\n1. patients receiving cabazitaxel: 48 cases (150 CTC samples)\n2. patients receiving enzalutamide: 90 cases (46 CTC samples)"}},{"key":"disease","label":{"ja":"疾患","en":"Disease"},"type":"disease","diseases":[{"terms":[{"code":"C61","label":{"ja":"前立腺の悪性新生物＜腫瘍＞","en":"Malignant neoplasm of prostate"}}],"name":{"ja":"進行転移性CRPC","en":"CRPC"}}]},{"key":"health-status","label":{"ja":"健康状態","en":"Health status"},"type":"vocabulary","terms":[{"code":"affected","label":{"ja":"罹患","en":"Affected"}}]},{"key":"subject-count","label":{"ja":"対象者数","en":"Subject count"},"type":"number","numbers":[{"value":127,"unit":null,"high":null}]},{"key":"subject-count-type","label":{"ja":"対象者数の数え方","en":"Counted as"},"type":"vocabulary","terms":[{"code":"individual","label":{"ja":"人数","en":"Individual"}}]},{"key":"sample-description","label":{"ja":"試料説明","en":"Sample description"},"type":"text","text":{"ja":"CTCから抽出したmRNA","en":"mRNAs extracted from CTC"}},{"key":"tissue","label":{"ja":"組織","en":"Tissue"},"type":"vocabulary","terms":[{"code":"circulating-tumor-cell","label":{"en":"Circulating tumor cell"}}]},{"key":"is-tumor","label":{"ja":"腫瘍 / 非腫瘍","en":"Tumor / normal"},"type":"vocabulary","terms":[{"code":"tumor","label":{"ja":"腫瘍","en":"Tumor"}}]},{"key":"sample-provider","label":{"ja":"試料の入手元","en":"Sample provider"},"type":"text","text":{"ja":null,"en":null}},{"key":"experimental-method","label":{"ja":"実験方法","en":"Experimental method"},"type":"vocabulary","terms":[{"code":"qrt-pcr","label":{"en":"qRT-PCR"}}]},{"key":"targets","label":{"ja":"測定対象","en":"Target"},"type":"text","text":{"ja":"アンドロゲン受容体、スプライシングバリアント7（AR-V7）","en":"androgen receptor expression, splicing variant 7 (AR-V7)"}},{"key":"reagents","label":{"ja":"試薬キット","en":"Reagent kit"},"type":"vocabulary","terms":[{"code":"adnatest-prostatecancerpanel-ar-v7","label":{"en":"AdnaTest ProstateCancerPanel AR-V7"}}]},{"key":"platform","label":{"ja":"プラットフォーム","en":"Platform"},"type":"vocabulary","terms":[{"code":"biorad-t100-thermal-cycler","label":{"en":"BioRad T100 Thermal Cycler"}}]},{"key":"analysis-methods","label":{"ja":"解析方法","en":"Analysis method"},"type":"text","text":{"ja":"Experion Software Version 3.0","en":"Experion Software Version 3.0"}},{"key":"policies","label":{"ja":"利用ポリシー","en":"Data use policy"},"type":"vocabulary","terms":[{"code":"nbdc-data-sharing-policy-jgap000001","label":{"ja":"NBDC データ共有ポリシー (JGAP000001)","en":"NBDC data sharing policy (JGAP000001)"}}]}]}],"fileFormats":[{"code":"xlsx","label":{"en":"XLSX"}},{"code":"zip","label":{"en":"ZIP"}}]}